Identify The Behavioral Criteria
- American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.).
- Baldessarini, R. J., et al. (2016). Pharmacotherapy of bipolar disorder: Current evidence and future directions. The Journal of Clinical Psychiatry, 77(3), e306-e315.
- Breslau, N., et al. (2014). Psychiatric disorders associated with traumatic events. Archives of General Psychiatry, 61(4), 359-366.
- Craddock, N., & Jones, I. (2013). Genetics of bipolar disorder and schizophrenia: Shared disease pathways. Nature Reviews Genetics, 14(9), 674-685.
- Hofmann, S. G., et al. (2012). The efficacy of cognitive behavioral therapy: A review of meta-analyses. Clinical Psychology Review, 32(2), 163-170.
- Kessler, R. C., et al. (2012). The global burden of anxiety and depressive disorders. Psychological Medicine, 42(7), 1349-1366.
- Malhi, G. S., et al. (2018). Bipolar disorder: Diagnosis and management. The Lancet, 392(10155), 783-795.
- Yehuda, R., et al. (2015). Post-traumatic stress disorder. Nature Reviews Disease Primers, 1, 15057.
Identify The Behavioral Criter
Identify the behavioral criteria of major DSM-5 categories: anxiety, trauma- and stressor-related, bipolar and related, and depressive disorders. Anxiety disorders include excessive fear, avoidance behaviors, and physical symptoms like trembling or sweating. Trauma- and stressor-related disorders involve intrusive thoughts, hyperarousal, and avoidance of trauma-related stimuli. Bipolar disorders are characterized by mood swings between manic and depressive episodes, including increased activity and irritability during mania. Depressive disorders feature persistent sadness, loss of interest, and changes in sleep or appetite. These disorders are prevalent worldwide, with genetic, environmental, and neurochemical factors contributing to their development. Understanding their behavioral patterns aids in diagnosis and treatment planning.
Paper For Above instruction
Depressive, anxiety, trauma- and stressor-related, and bipolar disorders are complex mental health conditions with distinct behavioral criteria outlined in DSM-5. Anxiety disorders manifest through persistent fear, excessive worry, avoidance behaviors, and physiological symptoms such as rapid heartbeat and sweating (American Psychiatric Association, 2013). These behaviors serve as a protective response to perceived threats, yet they often become maladaptive. Trauma- and stressor-related disorders, including PTSD, involve intrusive memories, hyperarousal, emotional numbness, and avoidance of trauma reminders, reflecting an ongoing struggle to process trauma (Yehuda et al., 2015). Bipolar disorder features alternating episodes of elevated mood, increased energy, impulsivity, and depression, with behavioral shifts corresponding to mood changes (Malhi et al., 2018). Depressive disorders are marked by persistently low mood, fatigue, social withdrawal, and changes in sleep and appetite, disrupting daily functioning (American Psychiatric Association, 2013).
Prevalence rates demonstrate that anxiety disorders affect approximately 18% of the population annually, while depressive disorders impact about 7% globally (Kessler et al., 2012). Trauma-related disorders often develop after exposure to traumatic events, influenced by genetic predisposition and traumatic severity (Breslau et al., 2014). Bipolar disorder has a lifetime prevalence of around 1-2%, with genetic and neurobiological factors playing roles (Craddock & Jones, 2013). Causes of these disorders include environmental stressors, neurochemical imbalances, and genetic vulnerabilities, emphasizing the importance of early intervention and comprehensive treatment approaches.
Contemporary treatments are grounded in theoretical models and current research. Cognitive-behavioral therapy (CBT) remains a cornerstone, targeting maladaptive thought patterns and behavioral responses across anxiety, depression, and trauma-related disorders (Hofmann et al., 2012). Pharmacological treatments, such as SSRIs for anxiety and depression, and mood stabilizers or antipsychotics for bipolar disorder, have demonstrated efficacy (Baldessarini et al., 2016). Emerging approaches include mindfulness-based therapy, trauma-focused CBT, and neuromodulation techniques like transcranial magnetic stimulation. Personalized treatments integrating biological, psychological, and social factors are increasingly favored, highlighting the importance of tailored interventions in contemporary mental health care.